Phase 4Completed

Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement (PEPPER)

Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement: Balancing Safety and Effectiveness

Sponsor
Dartmouth-Hitchcock Medical Center (Academic or other)
Enrolment
18,883 enrolled
Conditions
Pulmonary Embolism; Venous Thrombosis
Interventions
Enteric Coated Aspirin; Warfarin; Rivaroxaban
Ages
adults, older adults
Registry
NCT02810704

From the registry

PEPPER is a randomized study comparing the three most commonly used anticoagulants in North America in patients who have elected to undergo primary or revision hip or knee joint replacement surgery. The anticoagulants being compared are enteric coated aspirin, low intensity warfarin, and rivaroxaban.

Primary outcomes

  • Aggregate primary clinical endpoints of all-cause mortality plus PE and DVT
  • The frequency and nature of bleeding complications
  • Specific Joint Function
  • Patient Well- Being
Full record on ClinicalTrials.gov